The Secretary-General of the United Nations appealed to donor countries and others to pitch in USD 35 billion for a World Health Organization-led initiative that aims to speed the research and development of tests, treatments and vaccines for the coronavirus.
Without an infusion of USD 15 billion over the next three months, beginning immediately, we will lose the window of opportunity to advance research, increase manufacturing and start delivering new tests and drugs for COVID-19, said Antonio Guterres at the start of a WHO-led meeting on the initiative, known as the Act Accelerator.
He called for a quantum leap in funding to increase the chances of a global solution that could restore normality to the world. So far, the mechanism has received less than USD 3 billion.
WHO chief Tedros Adhanom Ghebreyesus warned the numerous deals struck by countries with pharmaceuticals to secure their own coronavirus vaccine doses could compromise equitable access and halt progress in bringing the COVID-19 pandemic to an end.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)